DIFFERINE

This brand name is authorized in France, Lithuania, Malta, Spain, Tunisia.

Active ingredients

The drug DIFFERINE contains one active pharmaceutical ingredient (API):

1	Adapalene UNII 1L4806J2QF - ADAPALENE
	Adapalene is a retinoid-like compound which in, in vivo and in vitro models of inflammation, has been demonstrated to possess anti-inflammatory properties. Mechanically, adapalene binds like tretinoin to specific retinoic acid nuclear receptors but, unlike tretinoin not to cytosolic receptor binding proteins. Adapalene is used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions.
	Read more about Adapalene

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D10AD03	Adapalene	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AD Retinoids for topical use in acne
Discover more medicines within D10AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	61066, 66158
FR	Base de données publique des médicaments	63066469, 69718483
LT	Valstybinė vaistų kontrolės tarnyba	1090121, 1091554, 1091555
MT	Medicines Authority	MA117/00201, MA117/00202, PI908/25201A, PI908/25202A
TN	Direction de la Pharmacie et du Médicament	7393071, 7393072